Clinical Trials

• Study of AM0010 With Nivolumab Compared to Nivolumab Alone Second-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
• Study of AM0010 With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer

Media Releases

News Releases 

Merrill Kingman Shum, MD, a Hematologist-Oncologist with The Oncology Institute of Hope & Innovation

 October 7, 2021  Karen Johnson Edit

Get to know Hematologist-Oncologist Dr. Merrill Kingman Shum, who serves patients in Whittier, California.

An exceptional, double-board certified, hematologist-oncologist, Dr. Shum serves as the Senior Medical Director and Medical Director of Dispensary at The Oncology Institute of Hope & Innovation (TOI). He enjoys day-to-day interaction, communication, touch and understanding that foster patient relationships, and considers it a privilege to treat his patients.

As the Senior Partner and Senior Medical Director for TOI, he has helped the center grow into the largest value-based care community oncology practice in the nation. He is the Co-Chair of the Physician Executive Committee.. He has been a lead principal investigator and sub-investigator in over 300 clinical trials and has helped facilitate several FDA drug approvals. He serves on several pharmaceutical drug advisory boards and serves as the Dispensary Medical Director for The Oncology Institute.

Founded in 2007, The Oncology Institute of Hope and Innovation is dedicated to excellence in cancer prevention, diagnosis, treatment, research, and education. It is the largest community, value-based, oncology practice in the US. With more than 50 practices in California, Arizona, Nevada, and Florida, they are part of the fabric of the communities they serve and committed to ensuring their services are easy to access.

Completing his undergraduate education at the University of California at Berkeley, Dr. Shum earned his medical degree from Autonoma University of Guadalajara in Jalisco, Mexico, and his fifth Pathway Certification from New York Medical College. He completed his residency at UMDNJ – Robert Wood Johnson Medical School (Cooper University Hospital) and served as Chief Institutional Fellow. He then pursued his fellowship at MD Anderson Cancer Center at Cooper. 

During his residency and fellowship, Dr. Shum received numerous honors and awards including the Arthur P. Gold Foundation Excellence in Humanism and Teaching Award, the Golden Apple Teaching Award, the Teaching Resident of the Year Award, the Internal Medicine Resident of the Year Award, Cambridge Who’s Who in Medicine, AMA Physician’s Recognition Award, NJ ACP Certificate of Merit, and the IRB Award for Contribution to Education and Research.

Subsequent to his education, the doctor attained board certification in internal medicine, hematology and medical oncology through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

A Southern California native, Dr. Shum returned to practice medicine in his home community after serving as an attending physician and member of the Crozer Regional Cancer Center, a Fox Chase Cancer Center affiliate in Philadelphia, Pennsylvania, for two years. During his tenure, he served as a relevance reviewer for the Hematology and Medical Oncology section from the American Board of Internal Medicine.

Among his prior academic appointments, he served as an adjunct Clinical Assistant Professor at the Lewis Katz School of Medicine at Temple University.

In good standing with a number of professional organizations, Dr. Shum is an active member of the American College of Physicians, the American Society of Clinical Oncology, and the American Society of Hematology. 

Among his most recent accolades and recognitions, Dr. Shum has been the recipient of the Top Doctor 2021 (California Magazine), the 2021 Super Doctors Award for Hematology-Oncology (Los Angeles Magazine), as well as the Physicians Achievement Award from the Presbyterian Intercommunity Hospital (PIH). He received the Southern California Rising Star Award (Los Angeles Magazine) for Hematology and Oncology from 2013 to 2015 and Super Doctors Award (Los Angeles Magazine) from 2017 to 2021. He was also recognized by Vitals’ website for Patient’s Choice Award in 2017 and 2018, On-Time Doctor Award in 2017 and 2018, and Compassionate Doctor Recognition in 2017.

He has 23 publications that can be found in the American Journal of Medicine, American Journal of Hematology, American Journal of Clinical Oncology, Breast Cancer Research and Treatment, Annals of Oncology, Blood, Proceedings American Journal of Clinical Oncology, Cancer Research, and the Journal of Thoracic Oncology. He has also submitted another abstract to the American Society of Hematology in December of 2021.

The youngest of a set of twins, Dr. Shum says his name in Chinese means “someone wise who helps others to become better.” Active in the charity, Toys for Tots, he plays Santa Claus for the children of patients undergoing treatment. His hobbies include playing the piano, skiing, playing tennis, and coin collecting. Speaking multiple languages, he is fluent in English, Spanish, and Cantonese Chinese.

Recommended Articles

• Potential Causes of Leukopenia

  IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...

• Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via Survey

  While patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...

• Treatment Options of Multiple Myeloma

  A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...

• Can Multiple Myeloma be Asymptomatic?

  Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...

• Stem Cell Therapy Puts 4-year-old's Ultra Rare Lymphoma in Remission

  4-year-old Jovon Moss was diagnosed with X-linked Lymphoproliferative Syndrome, a rare disorder of the immune system that led him to being taken back and forth to the hospital since his 3rd birthday.Jovon’s journey began in September of last year, when his mother, Brittany Fluellen, first began to...

• Treatments for Multiple Myeloma

  The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...